MwanzoINRLF • OTCMKTS
add
Valneva SE
Bei iliyotangulia
$ 3.27
Bei za mwaka
$ 1.88 - $ 4.62
Thamani ya kampuni katika soko
541.65M USD
Wastani wa hisa zilizouzwa
88.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
EPA
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 49.23M | 50.31% |
Matumizi ya uendeshaji wa biashara | 32.15M | 145.44% |
Mapato halisi | -9.23M | -115.67% |
Kiwango cha faida halisi | -18.75 | -110.42% |
Mapato kwa kila hisa | -0.14 | -115.41% |
EBITDA | -2.28M | -103.21% |
Asilimia ya kodi ya mapato | -19.00% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 152.99M | -13.39% |
Jumla ya mali | 482.24M | -4.09% |
Jumla ya dhima | 306.99M | -2.11% |
Jumla ya hisa | 175.25M | — |
hisa zilizosalia | 153.87M | — |
Uwiano wa bei na thamani | 2.87 | — |
Faida inayotokana na mali | -3.03% | — |
Faida inayotokana mtaji | -3.80% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (EUR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -9.23M | -115.67% |
Pesa kutokana na shughuli | -8.15M | 71.34% |
Pesa kutokana na uwekezaji | elfu -961.00 | -101.11% |
Pesa kutokana na ufadhili | -5.58M | 25.14% |
Mabadiliko halisi ya pesa taslimu | -15.28M | -130.22% |
Mtiririko huru wa pesa | -19.68M | -198.73% |
Kuhusu
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2013
Tovuti
Wafanyakazi
713
